AGE-RAGE in multiple sclerosis brain. (Q53418492)

14 May 2018

title

AGE-RAGE in multiple sclerosis brain. (English)

1 reference

14 May 2018

0 references

Zohara Sternberg

1

1 reference

14 May 2018

Peter Ostrow

2

1 reference

14 May 2018

Mary Vaughan

3

1 reference

14 May 2018

Trevor Chichelli

4

1 reference

14 May 2018

Frederick Munschauer

5

1 reference

14 May 2018

publication date

16 November 2010

1 reference

14 May 2018

Immunological Investigations

published in

1 reference

14 May 2018

volume

40

1 reference

14 May 2018

issue

2

1 reference

14 May 2018

page(s)

197-205

1 reference

14 May 2018

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Advanced protein glycosylation in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Lipid and lipoprotein modification by advanced glycosylation end-products: role in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Microglial activation and its implications in the brain diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Evaluation of rage isoforms, ligands, and signaling in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Identification of the advanced glycation end products N(epsilon)-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

BRCA1 protein products ... Functional motifs...

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Advanced glycation: a novel outlook on atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Expression of the receptor for advanced glycation end products in oligodendrocytes in response to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Neurotoxicity of acetaldehyde-derived advanced glycation end products for cultured cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Advanced glycation end-products and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

AGEs mediated expression and secretion of TNF alpha in rat retinal microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

New biomarkers of Maillard reaction damage to proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2010.532267

10.3109/08820139.2010.532267

21 January 2018

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018